Hepatitis C News and Research

RSS
Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.

The hepatitis C virus is usually transmitted through contact with the blood of an infected individual and, most commonly, people catch it through sharing contaminated needles when injecting illegal drugs.

Hepatitis C infection is categorized into an acute and a chronic stage. The acute phase describes the first 6 months of infection when there are not necessarily any symptoms. Around one quarter of people manage to clear the infection during this stage before disease progresses to the chronic stage.

People who go on to develop chronic hepatitis C may develop jaundice which turns the skin and whites of the eyes yellow. This is caused by the build-up of a yellow-colored substance in the blood called bilirubin that would usually be broken down by the liver if it was healthy. Chronic infection may eventually cause fibrosis and scarring (cirrhosis) of the liver, liver cancer or end stage liver failure.

Hepatitis C can be treated with antiviral medications that that are designed to disrupt the multiplication of virus particles inside the body and prevent liver damage.
A ‘safe’ space to shoot up: Worth a try in California?

A ‘safe’ space to shoot up: Worth a try in California?

Exclusive: White House task force echoes pharma proposals

Exclusive: White House task force echoes pharma proposals

People in recovery worry GOP Medicaid cuts would put treatment out of reach

People in recovery worry GOP Medicaid cuts would put treatment out of reach

Opana ER – a long acting opioid painkiller, to be pulled from the markets as per FDA directive

Opana ER – a long acting opioid painkiller, to be pulled from the markets as per FDA directive

UNC researchers identify how class of antiviral drugs interacts with HCV

UNC researchers identify how class of antiviral drugs interacts with HCV

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

New drug offers hope to patients with hepatitis C

New drug offers hope to patients with hepatitis C

Researchers develop new strategy that can revolutionize HIV vaccine design

Researchers develop new strategy that can revolutionize HIV vaccine design

Study finds substantial increase in hepatitis C infections among pregnant women

Study finds substantial increase in hepatitis C infections among pregnant women

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Study uncovers potential new therapeutic targets for HCV infections

Study uncovers potential new therapeutic targets for HCV infections

Specific genotype may predict recovery in patients with advanced cirrhosis after hepatitis c treatment

Specific genotype may predict recovery in patients with advanced cirrhosis after hepatitis c treatment

Discovery of protein that causes liver disease brings hope for new treatments

Discovery of protein that causes liver disease brings hope for new treatments

Improvements to animal testing protocols could yield more useful clinical results

Improvements to animal testing protocols could yield more useful clinical results

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

Latest advances in antibody delivery mediated by rAAV for treatment of chronic and infectious diseases

Latest advances in antibody delivery mediated by rAAV for treatment of chronic and infectious diseases

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

WHO Global Hepatitis Report reveals goal to eliminate viral hepatitis by 2030

Periodic check-ups are essential to maintain health and longevity of baby boomers

Periodic check-ups are essential to maintain health and longevity of baby boomers

New study reports long-term infectious disease trends in China after SARS outbreak

New study reports long-term infectious disease trends in China after SARS outbreak

Injection drug use linked to increase in immune activation, says researcher

Injection drug use linked to increase in immune activation, says researcher